Suppressing a protein turns ordinary fat into a calorie burner, study shows

FHS
July 1, 2024
11:21 pm

New UCSF study shows that suppressing a protein turns ordinary fat into a calorie burner and may explain why drug trials attempting the feat haven’t been successful.

Small personalized vaccine trial sees progress in late-stage kidney cancer

All nine late-stage kidney cancer patients in a Phase 1 trial of a personalized vaccine remained cancer-free after about three years of receiving treatment, researchers

February 6, 2025

Telix raises $398m to advance kidney and brain cancer radiotherapies – Pharmaceutical Technology

Eli Lilly, BMS, and Novartis have all conducted billion-dollar deals to claim a stake in the promising radiopharma space. Image credit: Shutterstock / Love Employee.

July 23, 2024

Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer

A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.